At a glance

ClinicalIndex Comparison Record

Phase 4Completed

Drug / intervention

Montelukast (drug)drug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00196547

NCT00196547Phase 4Completed

Compare CT.gov

Randomized Placebo-controlled Trial of Montelukast in Modulating Exacerbations of Asthma in Children, September 2005

Firestone Institute for Respiratory Health·interventional·Posted Sep 20, 2005·Updated Mar 16, 2012

In Brief

A Phase 4 clinical trial evaluating Montelukast (drug) for Asthma. Completed, across 1 site.

Detailed Summary

The purpose of the study is to determine if Montelukast added to other therapy, if any, will reduce the severity of asthma symptoms in children during the high incidence of respiratory viral infections that occur in children in the post Labor Day school return period.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsAsthma

CountriesCanada

Collaborators--

Timeline

Phase 4CompletedFinished

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartSep 2005

First PostedSep 2005

Study CompletionNov 2005

TodayJul 2026

First PostedSep 20, 2005

Enrollment StartSep 1, 2005

Study CompletionNov 1, 2005

TodayJul 2, 2026

Posted 20.8 years ago

Interventions

Montelukast (drug)drug